MAIA Biotechnology, Inc. (MAIA) Return on equity 2022–2024
MAIA Biotechnology, Inc. (MAIA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-639.8%FY2024 · since FY2022: -185.4% → -639.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -639.8% | +3501.0 pp |
| FY2023 | -4140.8% | -3955.5 pp |
| FY2022 | -185.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice